Half Year 2026 Sigma Healthcare Ltd Earnings Call Transcript
Key Points
- Sigma Healthcare Ltd (SIGGF) reported a strong first half performance with a 15% revenue growth, driven by robust network demand and consistent execution across markets.
- The company achieved $13 million in synergy benefits from its integration program, which is on track to meet its $100 million target by FY29.
- International operations are scaling well, with 12 new stores opened in New Zealand, Ireland, and Dubai, contributing to a 24.5% increase in network sales.
- The company launched over 400 new own and exclusive label products, which now account for nearly 10% of Chemist Warehouse store sales, supporting margin growth.
- Sigma Healthcare Ltd (SIGGF) declared a dividend of $0.02 per share, representing a payout ratio of close to 60%, indicating strong shareholder returns.
- The equity accounted profit line for New Zealand decreased year over year, despite strong sales growth, due to one-off items in the prior year.
- Admin and general expenses increased by about $30 million, or 17%, driven by international business growth and public company costs, which may impact future cost management.
- The company faces challenges in cross-selling additional products to GLP-1 medicine customers, indicating potential missed opportunities for revenue growth.
- There is uncertainty regarding the impact of GLP-1 medicines on future sales growth, as the category's long-term sustainability and margin effects remain unclear.
- The integration and synergy realization process is complex and long-term, with significant benefits expected only in the third and fourth years, posing execution risks.
Thank you for standing by and welcome to the Sigma Healthcare half year results announcement. As a reminder today all participants are in a listen-only mode. There will be a presentation followed by Xk one. You will need to press the star key followed by the number one on your telephone keypad. I would now like to hand the conference over to Mr. Vikesh Ramsunder managing director and CEO, please go ahead.
Good morning. I'm Vikesh Ramsander, the chief executive of Sigma Healthcare. And welcome to our half-year results presentation for the 6 months ending December 2025. I am joined here today by Richard Murray, who began his group CFfo in October, and Gary Woodford, our head of corporate affairs and investor relations. In terms of today's agenda, I will start with some of the key highlights for the half. Which is with them then take you to the financial performance in more detail. I will then provide some of our operational highlights and outlook before we open
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
